Fordham University            The Jesuit University of New York  

Back to News

Cancer Researcher Says, "We Have the Answer"


Cancer Researcher Says, “We Have the Answer”

Ronald A. DePinho, M.D., FCRH ’77, told a Fordham audience that scientists are closing in on a cure for cancer.

Photo by Chris Taggart

By Joanna Klimaski

A luminary in cancer research brought a message of hope to the Fordham community on Sept. 19, outlining the medical advances scientists have made in recent decades and identifying ways to address the remaining challenges.

Ronald A. DePinho, M.D., FCRH ’77, president of the University of Texas MD Anderson Cancer Center, presented “Conquering Cancer” for the Fordham University Science Council’s fall lecture, held at The University Club in Manhattan.

Dr. DePinho, an internationally recognized researcher who spent 14 years at Dana-Farber Cancer Institute and Harvard Medical School before assuming presidency of MD Anderson, said that medical advances have placed humanity at a turning point.

“This period of human history is going to go down as a major turning point for the human race,” Dr. DePinho told members of the Fordham community. “I believe that it’s going to rank up there with the discovery of fire and the advent of socialization.”

He called the cracking of the genetic code in 1953 a “seminal event” that prepared scientists today to understand life “on its most elemental level” and which had a huge impact on the successful treatment of disease.

However, there are new challenges as a result.

Thanks to improvements in vaccination, antibiotics, hygiene, and surgery, life expectancy has doubled worldwide. But a larger, older population means greater incidences of cancer, diabetes, and cardiovascular disease.

By 2050, he said, we could be spending $1 trillion on Alzheimer’s disease alone.

“We have a very significant issue … the changing demographics and the impact that this is going to have on our children and their children with respect to handling the burden of age-related disease,” he said.

Nevertheless, Dr. DePinho said he is confident that there is a solution.

“It’s science. It’s to understand these diseases sufficiently so that we can prevent them from happening in the first place, detect them early, or, if they occur, definitely resolve them.

“With today’s knowledge and technology, we actually can do that.”

On Sept. 21, Dr. DePinho publicly announced that MD Anderson would be launching a $3 billion initiative to dramatically reduce cancer deaths over the next 10 years. The Moon Shots Program, as it is known, will capitalize on technological advances to accelerate the pace at which scientific discoveries are turned into clinical practices. For patients diagnosed with the leading cancers—including lung cancer, melanoma, breast and ovarian cancers, prostate cancer, and three types of leukemia—Dr. DePinho said that a cure is in sight.

At Fordham, Dr. DePinho explained some key achievements that augured well for finding a cure. He said that when the human genome was first sequenced in the 1990s, it took 12 years and cost $3.6 billion to map one genome. Today, a human genome can be sequenced in just a few hours for $300.

With the curtailed cost of sequencing and ongoing improvements in genetic engineering that can ‘silence’ gene mutations, interdisciplinary researchers have begun mapping tens of thousands of tumors, so that healthcare professionals can target treatments for specific cancers.

Dr. DePinho, who was the 1977 Fordham salutatorian, also had a message for the students.

“When history writes how we conquered the great diseases, your generation will write the final chapter,” he said.


Fordham University Science Council

The Fordham University Science Council is a new initiative that promotes science, technology, engineering, and mathematics (STEM) initiatives at Fordham by supporting both students and faculty in their careers and research. Comprised of alumni, administrators, faculty, and students, the Science Council mentors Fordham students and connects them with opportunities to pursue research assistantships and internships.

“It started by trying to find out the status of the sciences at Fordham, and then became an advocacy body for the sciences,” said Robert D. Russo, M.D., FCRH ’69, chair of the Science Council.

“Now we’re building it by finding the alumni to help students to access corporations, other academic institutions, and healthcare facilities with the thought of getting them internships, fellowships, research grants, and contacts so that we can grow the sciences at Fordham.”

In addition to hosting public lectures and sponsoring events specifically for students, the Science Council is working to increase communication about the many ongoing efforts in the sciences at Fordham.

Dr. Russo said that 40 percent of this year’s incoming freshmen are specializing in a science, up from the 30 percent of freshman last year. Medical school acceptance rates are also at an impressive high, with last year reaching an 82 percent average acceptance rate, compared to the national average of 45 percent.

“There’s spectacular stuff going on and it’s all about a level of awareness about what everybody else is doing and how to get them to interact with each other,” Dr. Russo said.



More Top Stories in this issue:

Return to Top Stories index

Return to Inside Fordham home page

Copyright © 2012, Fordham University.

Site  | Directories
Submit Search Request